FG Begins Lenacapavir Rollout in Push to End HIV/AIDS by 2030

By George Omagbemi Sylvester

The Federal Government has begun the rollout of Lenacapavir, a long-acting injectable drug for HIV prevention, as part of its renewed push to end HIV/AIDS as a public health threat by 2030. The announcement was made in Abuja on Monday, March 23, 2026, by the Minister of State for Health, Dr Adekunle Salako, who said the first phase will commence in the Federal Capital Territory on Tuesday, March 24, 2026.

According to Salako, about 52,000 doses have been secured for the initial introduction of Lenacapavir for pre-exposure prophylaxis (LEN PrEP), with rollout also planned for Anambra, Ebonyi, Gombe, Kwara, Akwa Ibom, Cross River, and Benue states, in addition to the FCT. Nigeria was selected by the Global Fund as one of nine early adopter countries after expressing interest in March 2025.

Salako explained that Lenacapavir is designed for HIV-negative people at high risk of infection and is administered once every six months, making it more convenient than daily oral preventive drugs. Health officials say its discreet, long-acting nature could improve adherence and expand protection for key and vulnerable populations.

The move is significant because it shows Nigeria embracing newer scientific tools in a fight that has lasted decades. But the success of the programme will depend not just on rollout, but on awareness, access, continuity, and trust in the health system.


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *